Viral burden, inflammatory milieu and CD8⁺ T-cell responses to influenza virus in a second-generation thiazolide (RM-5061) and oseltamivir combination therapy study.

There was an overall trend for animals treated with RM‐5061 + OST to have lower total numbers of innate immune cells in BAL and spleen on d5 p.i. when compared to other treatment groups (Figure 2C ); however, this result was not statistically significant.

also in 4,871 other papers